DUBLIN, Aug. 14, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Contraceptives Market 2014-2018" report to their offering.
http://photos.prnewswire.com/prnh/20130307/600769
Contraception, also known as birth control or fertility control, refers to the use of methods or drugs or devices to prevent pregnancy as a consequence of sexual intercourse. Contraception methods can be temporary and permanent and are available to men and women. Permanent methods include male sterilization (vasectomy), and female sterilization including tubal occlusion or hysteroscopic sterilisation. Temporary methods can be hormonal and non-hormonal. The non-hormonal methods include condoms, diaphragms, sponges, withdrawal methods, cervical caps, and non-hormonal IUDs. Condoms, diaphragms, sponges, and cervical caps are also referred to as barrier contraception methods. Hormonal methods include oral contraceptive pills, contraceptive transdermal patches, vaginal rings, hormonal IUDs, and vaginal implants. Hormonal methods contain synthetic sex hormones estrogen/progestin or a combination of both which prevent ovulation and thicken cervical mucus in the female. Currently, hormonal methods can only be used by women. The development of a male hormonal contraceptive is an active research area.
The global contraceptives market can be segmented broadly into two divisions: Drugs and Devices. This report covers the present scenario and the growth prospects of the Global Contraceptives market for the period 2013-2018. To calculate the market size, the report considers revenue generated from the sales of various products used for contraception which include:
- Drugs (Oral Contraceptive Pills, Injectable Contraceptives, Topical Contraceptives)
- Devices (Male & Female condoms, Diaphragms, IUDs, Vaginal Rings, Female Sponges and Subdermal Contraceptive Implants)
The Global Contraceptives Market 2014-2018 report, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Contraceptives market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Topics Covered:
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
04. Market Research Methodology
05. Introduction
06. Market Landscape
07. Market Segmentation by Products Type
08. Global Contraceptives Drugs Market
09. Global Contraceptives Devices Market
10. Geographical Segmentation
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
19. Vendor Landscape
20. Key Vendor Analysis
21. Other Reports in this Series
Companies Mentioned:
- Actavis plc
- Adamis Pharmaceuticals Corp.
- Agile Therapeutics, Inc.
- ANI Pharmaceuticals, Inc.
- Ansell Ltd.
- Apothecus Pharmaceutical Corp.
- Bayer AG
- Blairex Laboratories Inc.
- Church & Dwight, Co. Inc.
- Caldwell Consumer Health, LLC.
- Ferring International Center S.A
- Fuji Latex Co., Ltd.
- HLL Lifecare Limited
- Johnson & Johnson's Janssen Pharmaceuticals, Inc.
- Karex Berhad
- Mayer Laboratories
- Medicines 360
- Merck & Co.
- Lipocine Inc.
- Lupin Pharmaceuticals, Inc.
- Mylan Laboratories Inc.
- Okamoto Industries, Inc.
- Pantarhei Bioscience B.V.
- Paul Hartmann AG
- Pfizer, Inc.
- Reckitt Benckiser Group Plc
- Teva Pharmaceutical Industries, Ltd
- The Female Health Company
For more information visit http://www.researchandmarkets.com/research/5kt24m/global
Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net
